Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
![]() |
Effectiveness of initial MS treatments in the COMBAT-MS trial: injectables, dimethyl fumarate, natalizumab and rituximabAlping, P. ; Burman, J. ; Fink, K. ; Fogdell-Hahn, A. ; Gunnarsson, Martin ; Hillert, J. ; Langer-Gould, A. ; Lycke, J. ; Nilsson, P. ; Olsson, T. ; Salzer, J. ; Svenningsson, A. ; Vrethem, M. ; Frisell, T. ; Piehl, F.MULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (Suppl. 2), p.21 [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Ata de Congresso
|
![]() |
Trajectories of processing speed, disability, and their connections, over the years following disease modulatory treatment initiation among relapsing-remitting multiple sclerosis patientsLonginetti, E. ; Englund, S. ; Burman, J. ; Fogdell-Hahn, A. ; Gunnarsson, Martin ; Hillert, J. ; Langer-Gould, A. ; Lycke, J. ; Nilsson, P. ; Salzer, J. ; Svenningsson, A. ; Vrethem, M. ; Olsson, T. ; Piehl, F. ; Frisell, T.MULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (Suppl. 2), p.677 [Periódico revisado por pares]Texto completo disponível |
3 |
Material Type: Ata de Congresso
|
![]() |
Baseline characteristics from the COMBAT-MS study: Initial analyses suggest main driver for therapy choice is geographic locationAlping, P. ; Burman, Joachim ; Fink, K. ; Gunnarsson, M. ; Lycke, J. ; Nilsson, P. ; Salzer, J. ; Vrethem, M. ; Langer-Gould, A. ; Svenningsson, A. ; Frisell, T. ; Piehl, F.MULTIPLE SCLEROSIS JOURNAL, 2017, Vol.23, p.714 [Periódico revisado por pares]Texto completo disponível |
4 |
Material Type: Ata de Congresso
|
![]() |
A Novel Double Imaging Camera (ANDICAM)DePoy, Darren L ; Atwood, Bruce ; Belville, Stanley R ; Brewer, David F ; Byard, Paul L ; Gould, Andrew ; Mason, Jerry A ; O'Brien, Thomas P ; Pappalardo, Daniel P ; Pogge, Richard W ; Steinbrecher, David P ; Teiga, Edward JProceedings of SPIE, 2003, Vol.4841, p.827-838SPIETexto completo disponível |
5 |
Material Type: Ata de Congresso
|
![]() |
Serious Infections in Two Large US and Swedish Rituximab-treated Multiple Sclerosis Cohorts (S26.007)Langer-Gould, Annette ; Smith, Jessica ; Piehl, Fredrik ; Li, Bonnie ; Frisell, ThomasNEUROLOGY, 2019, Vol.92 (15_supplement) [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Ata de Congresso
|
![]() |
Rapid optical manufacturing of hard ceramic conformal windows and domesDEGROOTE NELSON, J ; GOULD, A ; DWORZANSKI, D ; KLINGER, C ; WIEDERHOLD, B ; MANDINA, MProceedings of SPIE, the International Society for Optical Engineering, 2011, Vol.8016Bellingham WA: SPIETexto completo disponível |
7 |
Material Type: Ata de Congresso
|
![]() |
The Microlensing Planet Finder: completing the census of extrasolar planets in the Milky WayBennett, David P ; Bond, Ian ; Cheng, Edward ; Friedman, Scott ; Garnavich, Peter ; Gaudi, B. Scott ; Gilliland, Ronald ; Gould, Andrew ; Greenhouse, Matthew A ; Griest, Kim ; Kimble, Randy A ; Lunine, Jonathan I ; Mather, John C ; Minniti, Dante ; Niedner, Malcolm ; Paczynski, Bohdan ; Peale, Stanton ; Rauscher, Bernard J ; Rich, R. M ; Sahu, Kailash ; Tenerelli, Domenick ; Udalski, Andrzej ; Woolf, Neville ; Yock, PhilProceedings of SPIE, 2004, Vol.5487, p.1453-1464SPIETexto completo disponível |
8 |
Material Type: Ata de Congresso
|
![]() |
Outpatient infections, multiple sclerosis and disease-modifying therapiesLanger-Gould, A ; Smith, JB ; Piehl, F ; Li, BHMULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (2_SUPPL), p.635 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Ata de Congresso
|
![]() |
No association between rituximab infusion timing nor cumulative dose and hospitalization for COVID-19: evidence from the nationwide COMBAT-MS CohortMckay, KA ; Piehl, F ; Englund, S ; He, A ; Langer-Gould, A ; Hillert, J ; Frisell, TMULTIPLE SCLEROSIS JOURNAL, 2021, Vol.27 (2_SUPPL), p.60 [Periódico revisado por pares]Texto completo disponível |
10 |
Material Type: Ata de Congresso
|
![]() |
Mortality rates in large US and Swedish rituximab-treated multiple sclerosis cohortsLanger-Gould, A ; Piehl, F ; Smith, J ; Frisell, TMULTIPLE SCLEROSIS JOURNAL, 2018, Vol.24, p.35 [Periódico revisado por pares]Texto completo disponível |